Tretinoin Oral Capsule 10Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • Weekly Ad

Tretinoin: Oral capsule (10mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file DrugItem_5627.JPG
Vesanoid 10mg Cap
Genentech Inc
Pill Identification: VESANOID 10 ROCHE 
Drug Image file DrugItem_16113.JPG
Tretinoin 10mg Cap
Par Pharmaceuticals, an Endo Company
Pill Identification: TR 
Drug Image file DrugItem_26898.JPG
Tretinoin 10mg Cap
Par Pharmaceuticals, an Endo Company
Pill Identification: TR 
Drug Image file DrugItem_16788.JPG
Tretinoin 10mg Cap
American Health Packaging
Pill Identification: TR 
Drug Image file DrugItem_22689.JPG
Tretinoin 10mg Cap
AvKARE, Inc.
Pill Identification: TR 

What is this Medicine?

TRETINOIN (TRET i noe in) is a medicine belonging to a class called the retinoids. It is similar to vitamin A. It is used to treat certain leukemias, such as acute promyelocytic leukemia (APL).

Similar Brand Name Drugs : Vesanoid: Oral capsule (10mg)
In-Depth Information
Select a Medication

Tretinoin 10mg Capsule

NDC: 005550808
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Acute Promyelocytic Leukemia (APL)

Sometimes used for but not FDA approved for the following conditions:
Kaposi's Sarcoma

Storage Information
Protect from light
Store at controlled room temperature (between 68 and 77 degrees F)
Tretinoin 10mg Capsule

Reported Side Effects for Tretinoin 10mg Capsule

High Platelet Count Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Increased Blood Fats Incidence:
<60.0%*
Severity: MODERATE
Onset: DELAYED
Unusual Skin Lightening Incidence:
2.0%*
Severity: MILD
Onset: DELAYED
Darkened Skin Patches Incidence:
2.0%*
Severity: MILD
Onset: DELAYED
Brain Dysfunction Incidence:
3.0%*
Severity: MODERATE
Onset: DELAYED
Liver Infection Incidence:
3.0%*
Severity: MODERATE
Onset: DELAYED
Decreased Reflexes Incidence:
3.0%*
Severity: MILD
Onset: DELAYED
Shaking Incidence:
3.0%*
Severity: MILD
Onset: EARLY
Decreased Thinking Incidence:
3.0%*
Severity: MODERATE
Onset: EARLY
Heart Attack Incidence:
3.0%*
Severity: SEVERE
Onset: DELAYED
Low Body Temperature Incidence:
3.0%*
Severity: MILD
Onset: DELAYED
Fluid In Lungs Incidence:
3.0%*
Severity: SEVERE
Onset: EARLY
Convulsions Incidence:
3.0%*
Severity: SEVERE
Onset: DELAYED
Brain Attack Incidence:
3.0%*
Severity: SEVERE
Onset: EARLY
Can'T Recognize Things Incidence:
3.0%*
Severity: SEVERE
Onset: DELAYED
Unable To Speak Incidence:
3.0%*
Severity: MODERATE
Onset: DELAYED
Tremor Of Wrists Incidence:
3.0%*
Severity: MILD
Onset: DELAYED
Incoordination Incidence:
3.0%*
Severity: MODERATE
Onset: DELAYED
Dysarthria Incidence:
3.0%*
Severity: MODERATE
Onset: DELAYED
Heart Muscle Disease Incidence:
3.0%*
Severity: SEVERE
Onset: DELAYED
Drowsiness Incidence:
3.0%*
Severity: MILD
Onset: EARLY
Kidney Damage Incidence:
3.0%*
Severity: SEVERE
Onset: DELAYED
Kidney Failure Incidence:
3.0%*
Severity: SEVERE
Onset: DELAYED
Coma Incidence:
3.0%*
Severity: SEVERE
Onset: EARLY
Suddenly Stopped Heart Incidence:
3.0%*
Severity: SEVERE
Onset: EARLY
Extra Abdominal Fluid Incidence:
3.0%*
Severity: MODERATE
Onset: DELAYED
Stomach Ulcer Incidence:
3.0%*
Severity: SEVERE
Onset: DELAYED
Inflamed Heart Muscle Incidence:
3.0%*
Severity: SEVERE
Onset: DELAYED
Weakness Incidence:
3.0%*
Severity: MILD
Onset: EARLY
Inflamed Heart Incidence:
3.0%*
Severity: SEVERE
Onset: DELAYED
Laryngeal Edema Incidence:
3.0%*
Severity: SEVERE
Onset: RAPID
Increased Urination Incidence:
3.0%*
Severity: MILD
Onset: EARLY
High Pressure In Lungs Incidence:
3.0%*
Severity: SEVERE
Onset: DELAYED
Pale Skin Incidence:
6.0%*
Severity: MILD
Onset: EARLY
Heart Failure Incidence:
6.0%*
Severity: SEVERE
Onset: DELAYED
Deafness Incidence:
6.0%*
Severity: SEVERE
Onset: DELAYED
Swelling Incidence:
6.0%*
Severity: MODERATE
Onset: DELAYED
Hallucinations Incidence:
6.0%*
Severity: MODERATE
Onset: EARLY
Distressed Incidence:
9.0%*
Severity: MILD
Onset: EARLY
Removal Of Spleen Incidence:
9.0%*
Severity: MODERATE
Onset: DELAYED
Back Pain Incidence:
9.0%*
Severity: MODERATE
Onset: DELAYED
Painful Urination Incidence:
9.0%*
Severity: MODERATE
Onset: EARLY
Bleeding In The Brain Incidence:
9.0%*
Severity: SEVERE
Onset: DELAYED
High Pressure In Brain Incidence:
9.0%*
Severity: SEVERE
Onset: EARLY
Enlarged Liver Incidence:
9.0%*
Severity: MODERATE
Onset: DELAYED
Skin Irritation Incidence:
>10.0%*
Severity: MILD
Onset: EARLY
Dry Skin Incidence:
>10.0%*
Severity: MILD
Onset: DELAYED
Skin Redness Incidence:
>10.0%*
Severity: MODERATE
Onset: EARLY
High Blood Pressure Incidence:
11.0%*
Severity: MODERATE
Onset: EARLY
Irritated Blood Vessels Incidence:
11.0%*
Severity: MODERATE
Onset: RAPID
Confusion Incidence:
11.0%*
Severity: MODERATE
Onset: EARLY
Wheezing Incidence:
14.0%*
Severity: MODERATE
Onset: RAPID
Hair Loss Incidence:
14.0%*
Severity: MILD
Onset: DELAYED
Depression Incidence:
14.0%*
Severity: MODERATE
Onset: DELAYED
Upset Stomach Incidence:
14.0%*
Severity: MILD
Onset: EARLY
Low Blood Pressure Incidence:
14.0%*
Severity: MODERATE
Onset: RAPID
Inability To Sleep Incidence:
14.0%*
Severity: MILD
Onset: EARLY
Muscle Pain Incidence:
14.0%*
Severity: MILD
Onset: EARLY
Decreased Appetite Incidence:
17.0%*
Severity: MILD
Onset: DELAYED
Weight Loss Incidence:
17.0%*
Severity: MILD
Onset: DELAYED
Nervousness Incidence:
17.0%*
Severity: MILD
Onset: DELAYED
Visual Impairment Incidence:
17.0%*
Severity: SEVERE
Onset: EARLY
Constipation Incidence:
17.0%*
Severity: MODERATE
Onset: DELAYED
Paresthesias Incidence:
17.0%*
Severity: MILD
Onset: DELAYED
Lightheadedness Incidence:
20.0%*
Severity: MILD
Onset: EARLY
Fluid Around The Lungs Incidence:
20.0%*
Severity: SEVERE
Onset: DELAYED
Itching Incidence:
>20.0%*
Severity: MILD
Onset: RAPID
Diaphoresis Incidence:
20.0%*
Severity: MILD
Onset: EARLY
Weight Gain Incidence:
23.0%*
Severity: MILD
Onset: DELAYED
Flushing Incidence:
23.0%*
Severity: MILD
Onset: RAPID
Loose Stools Incidence:
23.0%*
Severity: MILD
Onset: EARLY
Abnormal Heart Rhythm Incidence:
23.0%*
Severity: SEVERE
Onset: EARLY
Ear Pain Incidence:
23.0%*
Severity: MILD
Onset: EARLY
Disseminated Intravascular Coagulation (DIC) Incidence:
26.0%*
Severity: SEVERE
Onset: DELAYED
Mouth Ulcers Incidence:
26.0%*
Severity: MODERATE
Onset: DELAYED
Fluid Retention Incidence:
29.0-52.0%*
Severity: MODERATE
Onset: DELAYED
Stomach Pain Incidence:
31.0%*
Severity: MILD
Onset: EARLY
Intestinal Bleeding Incidence:
34.0%*
Severity: SEVERE
Onset: DELAYED
High White Blood Cells Incidence:
40.0%*
Severity: MILD
Onset: DELAYED
Elevated Hepatic Enzymes Incidence:
50.0-60.0%*
Severity: MODERATE
Onset: DELAYED
Fluid Retention Incidence:
52.0%*
Severity: MODERATE
Onset: DELAYED
Skin Rash Incidence:
54.0%*
Severity: MILD
Onset: EARLY
Upset Stomach Incidence:
57.0%*
Severity: MILD
Onset: EARLY
Vomiting Incidence:
57.0%*
Severity: MILD
Onset: EARLY
Shortness Of Breath Incidence:
60.0%*
Severity: MODERATE
Onset: EARLY
Bleeding Incidence:
60.0%*
Severity: MODERATE
Onset: EARLY
Shivering Incidence:
63.0%*
Severity: MILD
Onset: RAPID
Tired Incidence:
66.0%*
Severity: MILD
Onset: EARLY
Feeling Sick Incidence:
66.0%*
Severity: MILD
Onset: EARLY
Bone Pain Incidence:
77.0%*
Severity: MODERATE
Onset: DELAYED
Fever Incidence:
83.0%*
Severity: MILD
Onset: EARLY
Headache Incidence:
86.0%*
Severity: MILD
Onset: EARLY
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
First Trimester

Class D - Adequate well-controlled or observational studies in pregnant women have demonstrated a risk to the fetus. However, the benefits of therapy may outweigh the potential risk. For example, the drug may be acceptable if needed in a life-threatening situation or serious disease for which safer drugs cannot be used or are ineffective.

Second Trimester

Class D - Adequate well-controlled or observational studies in pregnant women have demonstrated a risk to the fetus. However, the benefits of therapy may outweigh the potential risk. For example, the drug may be acceptable if needed in a life-threatening situation or serious disease for which safer drugs cannot be used or are ineffective.

Third Trimester

Class D - Adequate well-controlled or observational studies in pregnant women have demonstrated a risk to the fetus. However, the benefits of therapy may outweigh the potential risk. For example, the drug may be acceptable if needed in a life-threatening situation or serious disease for which safer drugs cannot be used or are ineffective.

Lactation

Avoid - This drug is known to cause harm to infants when taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Tretinoin

We want to help you stay educated about the medications you are taking. View other
patient's observations and share your own.

Be sure to consult your health care provider before taking any medications. Other
patient's comments should not be considered medical advice or health care provider
recommendations.